Wait...
  1. Home >
  2. Export Import News >
  3. SEZ >
  4. Zydus Cadila gets USFDA nod to market 2 drugs >
  5. Zydus Cadila gets USFDA nod to market 2 drugs

Online Export Import Data Search

Recent Searches: No Recent Searches
Complete Training Video : Click Here

Zydus Cadila gets USFDA nod to market 2 drugs.


Date: 26-04-2018
Subject: Zydus Cadila gets USFDA nod to market 2 drugs
New Delhi, Apr 25 () Drug firm Zydus Cadila today said it has received final approval from the US health regulator to market two drugs used for the treatment of various conditions, including blood disorders, certain types of cancers, kidney and lung ailments.  

The United States Food and Drug Administration (USFDA) has given its nod to market Zydus Cadila's Methylprednisolone tablets and Cinacalcet hydrochloride tablets in the American market. 

The approval has been granted for Methylprednisolone tablets USP in the strengths of 4 mg, 8 mg, 16 mg and 32 mg and Cinacalcet hydrochloride tablets in the strengths of 30 mg, 60 mg and 90 mg, Zydus Cadila said in a statement. 

Methylprednisolone tablets will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad, it added. 

The tablets are used to treat various conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin, kidney, intestinal, lung diseases and immune system disorders, Zydus Cadila said. 

The group has also received the final approval to market Cinacalcet hydrochloride tablets in the strengths of 30 mg, 60 mg and 90 mg. 

The product will be manufactured at the group's formulations manufacturing facility at SEZ Ahmedabad, Zydus Cadila said. 

The tablets are" indicated for the treatment of high blood calcium in patients with cancer of parathyroid glands and for the treatment of high blood parathyroid hormone levels seen in patients with chronic kidney disease on dialysis," it added. 

Shares of Cadila Healthcare, the listed entity of the group, today closed at Rs 402.20 per scrip on BSE, down 0.51 per cent from their previous close.

 Source: timesofindia.indiatimes.com

Get Sample Now

Which service(s) are you interested in?
 Export Data
 Import Data
 Both
 Buyers
 Suppliers
 Both
OR
 Exim Help
+




Exim Guru Copyright © 1999-2019 Exim Guru. All Rights Reserved.
The information presented on the site is believed to be accurate. However, InfodriveIndia takes no legal responsibilities for the validity of the information.
Please read our Terms of Use and Privacy Policy before you use this Export Import Data Directory.

EximGuru.com

C/o Infodrive India
E-2, 3rd Floor, Kalkaji Main Road
New Delhi - 110019, India
Phone : 011 - 40703001